Lavender (Lavandula officinalis), the source of the essential oil used in supplements, has been the subject of numerous studies that have confirmed its multiple phytotherapeutic abilities. However, despite the evident effectiveness of this substance, the main challenge remains the optimal absorption of the active ingredients by the body.

In this context, IPS emerges as a cutting-edge raw material supplier, capable of overcoming this obstacle through the technique of microencapsulation.

Microencapsulation by coacervation ensures the preservation of the therapeutic properties of lavender oil, but it also solves the problem of its typical bitter taste, which is sometimes not well-received by consumers. It often happens that the taste of the ingredients contained in some supplements is too strong and the consumer is not inclined to take them, despite the benefits that could be derived. IPS microcapsules are also designed to mask the odors and flavors of the active ingredients, using a polymeric membrane.

Thanks to the widespread distribution of the active ingredient in the gastrointestinal tract, IPS microcapsules deliver the active principles directly to the point of maximum effectiveness, ensuring prolonged and optimal release.

The microcapsules contain between 80 and 90% lavender oil, titrated to 20-50% Linalool and 20-30% Linalyl Acetate. These main components are known for their beneficial and therapeutic actions, including sedative, analgesic, and antispasmodic effects.

The solution offered by IPS effectively meets the needs of modern consumers, who are increasingly oriented towards natural products but demanding in terms of effectiveness and pleasantness of use. By relying on IPS, manufacturers can be sure they are working with a partner capable of providing innovative and high-quality raw materials, essential for the development of effective and competitive dietary and nutraceutical supplements.